MRI changes in cerebrotendinous xanthomatosis after treatment with chenodeoxycholic acid

Rivista di Neuroradiologia

Volumn 11, Issue SUPPL. 2, 1998, Pages 8-9

  Lui, C C ^a   Chang, W N ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cerebrotendinous xanthomatosis; Chenodeoxycholic acid; Magnetic resonance imaging

Indexed keywords

CHENODEOXYCHOLIC ACID;

ADULT; CASE REPORT; CEREBROTENDINOUS XANTHOMATOSIS; CONFERENCE PAPER; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FEMALE; HUMAN; MALE; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; SIBLING;

EID: 0032445174     PISSN: 11209976     EISSN: None     Source Type: Journal    
DOI: 10.1177/19714009980110s203     Document Type: Conference Paper

References (3)

1. Chang WN, Kuriyama M et Al: Cerebrotendinous xanthomatosis in three siblings from a Taiwanese family. J Formosan Med Assoc 91: 1190-1194, 1992.
2. Berginer VM, Salen G, Shefer S: Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 311: 1649-1652, 1984.
3. Berginer VM, Berginer J et Al: Magnetic resonance imaging in cerebrotendinous xanthomatosis: a prospective clinical and neurological study. J Neurol Sci 122: 102-108, 1994.